Compare BCBP & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCBP | PMN |
|---|---|---|
| Founded | 2000 | 2004 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.1M | 115.5M |
| IPO Year | 2005 | 2022 |
| Metric | BCBP | PMN |
|---|---|---|
| Price | $10.47 | $10.53 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $10.00 | ★ $42.67 |
| AVG Volume (30 Days) | ★ 184.2K | 16.1K |
| Earning Date | 04-21-2026 | 05-13-2026 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $85.26 | N/A |
| Revenue Next Year | $6.14 | N/A |
| P/E Ratio | $39.50 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.31 | $0.29 |
| 52 Week High | $11.71 | $27.40 |
| Indicator | BCBP | PMN |
|---|---|---|
| Relative Strength Index (RSI) | 45.95 | 51.45 |
| Support Level | $7.61 | $10.55 |
| Resistance Level | $10.50 | $11.37 |
| Average True Range (ATR) | 0.35 | 0.58 |
| MACD | -0.13 | 0.09 |
| Stochastic Oscillator | 38.66 | 74.37 |
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.